新冠疫情背景下中药元素融入新药研制与报批课程的教学探索  

Teaching Exploration of Integrating Traditional Chinese Medicine Elements into the Course of New Drug Development and Approval under the Background of COVID-19

作　　者：涂清波 钱洁 单鑫 朱安宏 Tu Qingbo;Qian Jie;Shan Xin;Zhu Anhong(Nanjing University of Chinese Medicine Hanlin College,Taizhou 225300,China)

机构地区：[1]南京中医药大学翰林学院,江苏泰州225300

出　　处：《云南化工》2022年第11期168-170,共3页Yunnan Chemical Technology

基　　金：江苏省高校哲学社会科学研究项目(NO:2020SJA2408);2020年南京中医药大学翰林学院课程思政精品课程(分析化学)。

摘　　要：新药研制与报批是一门基于当前新药研发形势和药政制度的综合性课程,存在内容更新快和覆盖广的特点,为更好地学习新的课程知识应结合新冠疫情背景,将中药元素融入到课程的每个章节,采用PBL教学方法,形成网络与设计联合课堂教学体系。经课程过程评价,表明该教改课程有利于学生的爱国思想和实践创新能力的培养,为疫情背景下中药特色课程的教学探索道路。New drug development and approval is a comprehensive course based on the current new drug development situation and drug administration system.It has the characteristics of fast updating and wide coverage,so as to better learn new course knowledge.Methods:Combined with the background of COVID-19,traditional Chinese medicine elements are integrated into each chapter of the course,and PBL teaching method is adopted to form a joint classroom teaching system of network and design.Results:The evaluation of the course process shows that the teaching reform course is conducive to the cultivation of students’ patriotism and practical innovation ability.Conclusions:This course has novel teaching reform scheme and diversified teaching system,which explores the way for the teaching of traditional Chinese medicine characteristic courses under the background of epidemic situation.

关 键 词：新冠疫情 中药元素 新药研制与报批 PBL 

分 类 号：G642[文化科学—高等教育学]